Feds announce Part D cost increases for 2007

 
The Center for Medicare & Medicaid Services (CMS) has announced the increased costs for the Standard Part D parameters that will take effect in January 2007. 
 
2007 will see the following changes:
 
* Deductible will go up from $250 to $265.
 
* Beginning of coverage gap ("donut hole") will go up from $2,250 to $2,400 in total drug cost.
 
* End of coverage gap ("donut hole") will go up from $5,100 to $5,451.25.
 
The amount of money a Medicare recipient will have to spend out of their own pocket on drugs to get out of the coverage gap and begin receiving the 95% "catastrophic" coverage will go up from $3,600 to $3,850 for the year.
 
The law requires CMS to increase the cost of the deductible and the beginning/ending of the coverage gap each year based on the increase in drug spending by Medicare beneficiaries in the previous year -- a rate much higher than the Consumer Price Index.  The new rates for 2007 are an increase of 6.8%.  The Consumer Price Index, which measures overall inflation/price increases (and is used in determining Social Security and other cost-of-living increases) for the same period will be only 1.81%
 
Real Medicare drug benefit needed now!
 
Less than 4 months into the private Part D drug plan, it's official -- a bad deal is going to get worse next year and every year after.
 
Recent studies have shown that compared to the cost of the private Part D plan, a Medicare run drug benefit with negotiated lower drug prices could provide 100% of recipients drug costs -- with no premium, deductible, coverage gap -- and still have a surplus of $40 billion over the first 7 years.
 
It's time for Congress to fix this private Part D disaster and create a real drug benefit run by and through Medicare with negotiated lower drug prices.
 
Steve Pittman
Illinois Alliance for Retired Americans
1634 W. Van Buren, Chicago IL 60612
312-243-6296 [phone]
312-243-9532 [fax]


 


 

 

 

 

.

 
   

.

.

 

 

 

 

Home // Feedback // Search
© 2005 IAM District W-3. All rights reserved.